<DOC>
	<DOCNO>NCT02091778</DOCNO>
	<brief_summary>The primary objective post market clinical follow-up ( PMCF ) investigation evaluate performance safety fast gel dress use intend Diabetic Foot Ulcer ( DFU ) . The primary endpoint Changes baseline condition peri-wound skin measure following variable ; maceration , redness/irritation , rash/eczema , blistering , dermatitis , skin stripping , trauma wound edge product degradation skin</brief_summary>
	<brief_title>Open , Non-comparative , Multi-centre Post Marketing Clinical Follow-up Investigation Evaluate Performance Safety Diabetic Foot Ulcer , DFU When Using Fast Gelling Dressing Intended .</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Both gender ≥18 year old . 2 . Subjects type 1 2 diabetes mellitus . 3 . Texas Grade A1 2 , C1 2 4 . Exuding diabetic foot ulcer 5 . Ulcer localisation ; ankle 6 . Signed Informed Consent . 1 . Known allergy/hypersensitivity dress . 2 . HbA1c ≥ 10 % ( 86 mmol/mol ) ( recent value within 3 month ) 3 . Wound infection require systemic treatment 4 . Subjects problem follow protocol . 5 . Subjects include ongoing clinical investigation present past 30 day . 6 . Toe pressure le 70 mmHg 7 . Clinical suspicion osteomyelitis ( base probe bone/radiological change ) 8 . Dry wound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>